Literature DB >> 1440803

The effect of artemisinine, its derivatives and mefloquine against chloroquine-resistant strains of Plasmodium falciparum in vitro.

M Hassan Alin1, A Björkman, A Landberg-Lindgren, M Ashton.   

Abstract

A 48 h in vitro test of the efficacy of artemisinine, dihydroartemisinine, artemether, mefloquine and chloroquine was carried out against 3 chloroquine-resistant strains of Plasmodium falciparum, strains K1 and T996 from Thailand and LS21 from India. A sigmoid Emax model was fitted to all in vitro inhibition data for each combination of drug and strain. Strains K1 and LS21 were strongly resistant to chloroquine, whereas T996 was partially resistant. Artemisinine, dihydroartemisinine and artemether were active against all strains, with complete growth inhibition at 10(-7) M. Artemether and dihydroartemisinine were both more potent than artemisinine, with 50% effective (EC50) values of 0.57-1.6 nM and 0.36-3.1 nM respectively; the EC50 of artemisinine was 1.5-6.1 nM for the 3 strains. The EC50 values for mefloquine were 46-185 nM. At higher concentrations, strains K1 and LS21 were fully inhibited, while with strain T996 mefloquine did not fully inhibit even at the highest concentration, 1.28 x 10(-6) M. It is concluded that artemisinine and its derivatives were highly effective against the 3 chloroquine-resistant strains, one of which showed borderline resistance to mefloquine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1440803     DOI: 10.1016/0035-9203(92)90220-7

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Effect of food intake on pharmacokinetics of oral artemisinin in healthy Vietnamese subjects.

Authors:  T K Dien; P J de Vries; N X Khanh; R Koopmans; L N Binh; D D Duc; P A Kager; C J van Boxtel
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

2.  A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria.

Authors:  K T Batty; L T Thu; T M Davis; K F Ilett; T X Mai; N C Hung; N P Tien; S M Powell; H V Thien; T Q Binh; N V Kim
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

Review 3.  Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria.

Authors:  P J de Vries; T K Dien
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

4.  Simple, fast, and accurate fluorometric method to determine drug susceptibility of Plasmodium falciparum in 24-well suspension cultures.

Authors:  L J Smeijsters; N M Zijlstra; F F Franssen; J P Overdulve
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

Review 5.  Progress in the research of artemisinin-related antimalarials: an update.

Authors:  H J Woerdenbag; N Pras; W van Uden; T E Wallaart; A C Beekman; C B Lugt
Journal:  Pharm World Sci       Date:  1994-08-05

6.  Orally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover study.

Authors:  Tran Tinh Hien; Warunee Hanpithakpong; Nguyen Thanh Truong; Nguyen Thi Dung; Pham Van Toi; Jeremy Farrar; Niklas Lindegardh; Joel Tarning; Michael Ashton
Journal:  Clin Ther       Date:  2011-05       Impact factor: 3.393

7.  Population pharmacokinetic properties of artemisinin in healthy male Vietnamese volunteers.

Authors:  Sofia Birgersson; Pham Van Toi; Nguyen Thanh Truong; Nguyen Thi Dung; Michael Ashton; Tran Tinh Hien; Angela Abelö; Joel Tarning
Journal:  Malar J       Date:  2016-02-16       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.